Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
3.490
+0.140 (4.18%)
Mar 14, 2025, 10:55 AM EDT - Market open
Exagen Employees
As of December 31, 2023, Exagen had 179 total employees, including 174 full-time and 5 part-time employees. The number of employees decreased by 25 or -12.25% compared to the previous year.
Employees
179
Change (1Y)
-25
Growth (1Y)
-12.25%
Revenue / Employee
$310,844
Profits / Employee
-$84,441
Market Cap
61.56M
Employees Chart
XGN News
- 2 days ago - Exagen Inc. (XGN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights - GlobeNewsWire
- 16 days ago - Exagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025 - GlobeNewsWire
- 5 weeks ago - Exagen Inc. to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results - GlobeNewsWire
- 3 months ago - Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD - GlobeNewsWire
- 4 months ago - Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform - GlobeNewsWire
- 4 months ago - Exagen, Inc. (XGN) Q3 2024 Earnings Call Transcript - Seeking Alpha